Glenmark receives FDA warning letter for Baddi plant
Mumbai-based Glenmark Pharmaceuticals has been issued an FDA warning letter for manufacturing issues at its Baddi plant.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Warnings